2016г. №3 (24)


This information is intended for healthcare professionals only!


AB Popova, DN Nozadze, IV Sergienko
The role of PCSK9 in coronary vascular disease development - p. 5

N. G. Gogolashvili
Safety issues of atorvastatin usage in patients with a chronic kidney disease - p. 15

Original Articles
A. S. Tereshchenko, G. K. Arutyunyan, V. M. Mironov, E. V. Merkulov, A. N. Samko
Evaluation of the utility of manual thromboaspiration for coronary blood flow recovery in patients with ST elevation myocardial infarction - p. 30

A.Ye.Filippov, A. G. Obrezan, B. V. Pomogaybo, P. V. Bovtyushko
Risk assessment of clinical atherosclerosis complications by the estimation of common carotid and femoral arteries’ intima-media thicknes - p. 39

S. V. Byazrova, S. G. Kozlov, Z. A. Gabbasov, O. S. Saburova, V. P. Masenko
Serum levels of soluble form of receptor for advanced glycation end products in type 2 diabetes mellitus patients with restenosis after intracoronary drug eluting stent implantation - p. 47

AN Sumin, NA Bezdenezhnykh, NV Fedorova, AV Shcheglova, EV Indukaeva, GV Artamonova
The values of cardio-ankle vascular index in patients with impaired glucose metabolism according to research «ECVE-RF» in the Kemerovo region - p. 55

N. А. Sukhaterina
Dynamics of lipid spectrum and markers of inflammation in the patients receiving atorvastatin in hypertensive patients combined with chronic obstructive pulmonary disease - p. 68

E. M. Stakhneva, E. V. Kashtanova, Ya. V. Polonskaya, A. V. Kurguzov, O. V. Kamenskaya, Yu.I. Ragino, A. M. Chernyavskiy
The relationship of hormones of adipose tissue with inflammatory markers and homocysteine in coronary atherosclerosis - p. 75

A. V. Ponasenko, M. V. Khutornaya, A. G. Kutikhin, I. I. Zhidkova, A. S. Golovkin, O. L. Barbarash, L. S. Barbarash
Association of TLR gene polymorphisms with the severity of coronary atherosclerosis in patients with stable coronary artery disease - p. 80

N. А. Sukhaterina
Factors of inflammation, antioxidant protection and myocardial damage in coronary artery bypass graft in patients with single and multivessel coronary disease - p. 89

A. V. Bezdenezhnykh, A. N. Sumin, Y. V. Kazachek, A. V. Osokina, Y. V. Bayrakova, N. V. Kondrikova, S. V. Ivanov, O. L. Barbarash
Multifocality and progression of non-coronary atherosclerosis in patients undergoing coronary artery bypass grafting - p. 95

N. V. Kokh, E. N. Voronina, G. I. Lifshits
APOE gene polymorphism is a risk factor for dyslipidemia and potential pharmacogenetic marker of lipid-lowering therapy - p. 107

of the International Satellite Symposium of the 84th Congress of the European Atherosclerosis Society, dedicated to the problems of the study of lipoprotein (a) - p. 116

Download Abstracts

Sign in or Sign up to download journal (only in Russian, free)